Repurposing current medicines focused on identified drug targets is very likely to supply a extra rapid hope of tackling COVID-19 than establishing and producing a vaccine, argue an international workforce of researchers in the British journal Pharmacology Today.
Considering the fact that the emergence of the coronavirus in late 2019, extra than 3.5 million people are identified to have been contaminated, foremost to above 240,000 fatalities worldwide from COVID-19 as of May possibly one. The race is on to locate new medicines to address COVID-19 patients, and to create a vaccine to reduce infection in the initially put.
A workforce of scientists representing the International Union of Essential and Scientific Pharmacology explained there will be no “magic bullet” to address the illness and contend that a multi-pronged tactic is needed to locate new medicines. They warning that an successful and scalable vaccine is very likely to get extra than a